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Recent studies have demonstrated that drug antimicrobial activity is enhanced when metallic nanoparticles are used as an
inorganic support, obtaining synergic effects against microorganisms. The cationic antimicrobial peptide ubiquicidin 29–41
(UBI) has demonstrated high affinity and sensitivity towards fungal and bacterial infections. The aim of this research was
to prepare and evaluate the antimicrobial efficacy of engineered multivalent nanoparticle systems based on silver or gold
nanoparticles functionalized with UBI. Spectroscopy techniques demonstrated that NPs were functionalized with UBI mainly
through interactions with the -NH2 groups. A significant increase in the antibacterial activity against Escherichia coli and
Pseudomonas aeruginosawas obtained with the conjugate AgNP-UBI with regard to that of AgNP. No inhibition of bacterial growth
was observedwith AuNP andAuNP-UBI using a nanoparticle concentration of up to 182𝜇gmL−1. Nonetheless, silver nanoparticles
conjugated to the UBI antimicrobial peptide may provide an alternative therapy for topical infections.
1. Introduction
Awide variety of nanotechnological devices for the treatment
of infectious diseases have been developed, including micro-
emulsions [1], vaccines [2, 3], and metallic- [4, 5], inorganic-
[6], lipid-, and polymeric-based nanoparticles (NPs) [7].
Metallic NPs such as silver (AgNP) and gold (AuNP)
show unique and considerably distinct physical, chemical,
and biological properties due to their high surface-to-volume
ratio, with which surfaces can be modified with ligands
containing functional groups, providing an electrostatic or
steric stabilization [8].
The antibacterial activity of AgNPs against a broad spec-
trum of bacteria is well-known. AgNPs have been conjugated
to different molecules with antibacterial activity in order
to obtain synergic effects, such as poly(ethyleneimine) [9],
amoxicillin [10], polysaccharides [11], peptides [12], surfac-
tants, and polymers [13].
Recent studies demonstrated that AuNPs also have
antimicrobial activity [14]. Different techniques for NP
surface synthesis and functionalization with antimicrobial
drugs through covalent or noncovalent interactions have
been described, such as amoxicillin-coated AuNPs [15], van-
comycin-capped AuNPs [16], and ampicillin-, streptomycin-,
and kanamycin-conjugated AuNPs [17], as well as cefaclor-
[18] and aminoglycoside-conjugated AuNPs [19]. The afore-
mentioned studies are in agreement that the use of nanopar-
ticles combined with other antimicrobial effects can help
reduce intrinsic toxicity of nanoparticles for mammalian
cells, enhance the microbicidal effect by increasing damage
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mechanisms, and diminish the probability development of
resistance.
Antimicrobial peptides (AMP) represent ancient host
defence effectormolecules.The basis of antimicrobial activity
is the interaction of the peptide’s cationic domains (positively
charged) with the surface of microorganisms (negatively
charged). The membranes of the latter expose negatively
charged lipoteichoic acid and phospholipids while, in normal
mammalian cells, negatively charged lipids face the cyto-
plasm. These properties explain the poor binding of cationic
peptides to mammalian cells and the selective binding to
bacteria in physiological conditions [20].
The cationic antimicrobial peptide ubiquicidin is present
in human skin. Several studies have shown that the syn-
thetic antimicrobial peptide fragment ubiquicidin (29–41)
(TGRAKRRMQYNRR; 1,693Da) is a very sensitive and
specific agent for the scintigraphic detection of bacterial
and fungal infections in humans, making the differentiation
between an infection and noninfectious processes possible.
[21–25].The broad spectrum of antimicrobial peptidesmakes
them suitable for future medical applications; in this sense,
nanotechnology provides promising alternatives for peptide
transport and targeted delivery with strongly enhanced bio-
cidal properties and significant reduction of toxicity.
The aim of this research was to evaluate the antimicro-
bial efficacy of engineered multivalent nanoparticle systems
based on silver or gold nanoparticles functionalized with the
antimicrobial peptide ubiquicidin 29–41 (UBI).
2. Material and Methods
2.1. Materials. Ubiquicidin 29–41 [H-Thr-Gly-Arg-Ala-Lys-
Arg-Arg-Met-Gln-Tyr-Asn-Arg-Arg-OH;MW1693.0] (Bachem,
USA), Muller-Hilton agar (Bioxon, Becton Dickinson), sil-
ver nitrate (AgNO3), tetrachloroauric acid (HAuCl4⋅3H2O),
trisodium citrate dihydrate (Na3C6H5O7), sodium dodecyl
sulfate, and solvents were purchased from Sigma-Aldrich
Chemical Co. and used as received. All water was deionized
and sterile, obtained from a MilliQ purified water system.
2.2. Synthesis and Stabilization of Silver and Gold Nanoparti-
cles. Gold nanoparticles were prepared by citrate reduction
of tetrachloroauric acid according to the method described
by Kimling et al. [26]. Silver nanoparticles were prepared
according to Dong et al.’s procedure [27]. Nanoparticles were
purified by dialysis against injectable-grade water during
24 h and sterilized by membrane filtration with a 0.22𝜇m
filter (Millipore, Bedford, Massachusetts, USA). Posteriorly,
NPs were stabilized with the sodium dodecyl sulfate (SDS)
surfactant in order to prevent NP aggregation and establish a
suitable surface for peptide adsorption. SDS (1mL, 0.05%w/w)
was added to 100mL of the nanoparticle suspension (AgNP
or AuNP) and stirred for 10min. The mixture was then
purified by size-exclusion chromatography (PD-10 column)
using injectable-grade water as eluent. The peak obtained
(3.0–4.0mL) corresponded to the void volume of the column,
which contained AuNP-SDS or AgNP-SDS. The volume
mean diameter measured by DLS was not significantly
different from nonstabilized nanoparticles.
2.3. Determination of Gold and Silver Content. Gold content
was quantified through potentiometric titration of gold (III).
A constant volume of gold nanoparticles was oxidized by a
HF/aqua regia mixture and determined through Robles et
al.’s methodology [28]. Silver content was determined using
a back titration, following Volhard’s method described by Xu
et al. [29].
2.4. Conjugation and Standardization of Stabilized Nanopar-
ticles to the UBI Peptide. In order to determine the stability
of the NP-UBI colloidal suspension, different volumes (from
20𝜇L to 100 𝜇L) of 20𝜇M UBI were added to 1mL of
stabilized SDS-NPs and 𝑡 were then stirred for 15 minutes
at room temperature. Z-potential (Microtrac, USA) was
then measured to determine the peptide’s effect on colloidal
stability.
Once the most stable suspension was selected, it was
scaled as follows: 750 𝜇L of UBI (29–41) 20 𝜇M (1.5 ×
10−8mol) was added to 25mL of stabilized SDS-NPs. The
peptide/NP radio was calculated and adjusted to obtain
5–20 peptides per nanoparticle. Finally, functionalized NPs
were purified and concentrated using ultracentrifugation
(22,000 rpm for 20 minutes at −4∘C). The final suspension
of AuNP-UBI or AgNP-UBI was spectrophotometrically
adjusted to an absorbance of 1 u.a. and stored (in darkness at
4∘C) for further use.
2.5. Physiochemical Characterization
2.5.1. UV-Vis Spectroscopy. Absorption spectra, in the range
of 400–700 nm, were obtained with a Thermo Genesys 10S
spectrometer using a 1 cm quartz cuvette. Conjugates were
measured by UV-Vis analysis to monitor the AuNP, AuNP-
UBI, AgNP, andAgNP-UBI surface plasmon resonance band.
2.5.2. Particle Size and Zeta Potential. AgNPs and AuNPs
functionalized to UBI were measured (𝑛 = 5) using a particle
size (dynamic light scattering) and Z-potential analyser
(Nanotrac Wave, Model MN401, Microtract, FL, USA).
2.5.3. Infrared Spectroscopy. The FT-IR spectra of lyophilized
samples were acquired on a Perkin Elmer System 2000
spectrometer with an ATR platform (Pike Technologies)
by applying Attenuated Total Reflection Fourier Transform
Infrared (ATR-FTIR) spectroscopy from 570 to 4400 cm−1.
2.5.4. Raman Spectroscopy. Raman spectra of the samples
were performed on a MicroRaman OLYMPUS BX 41 spec-
trometer with a wavelength of 632.817 nm, a D0.6 filter,
and a 100 microhole filter/array. Ten scans of 60 s were
acquired on a pretreated glass cover (washed in three steps):
1HNO3/3HCl (v/v) solution, bidistilled water, and injectable
water. 10 𝜇L aliquots of the sample were deposited and dried
under nitrogen atmosphere at room temperature in a laminar
flow hood.
2.5.5. XPS Spectroscopy. X-ray photoelectron spectra were
acquired on a Jeol JPS 9200 spectrometer equipped with a
MgKR X-ray source operated at 10 kV/20mA and calibrated
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using Au 4f7/2 (84.0 eV) and Ag 3d5/2 (368.2 eV) from foil
samples. The collection was made using 20 scans for Au
4f and Ag 3d with energy step size of 0.1 eV. The binding
energies were referenced to the C 1 s peak at 284.3 eV. From all
spectra, a Shirley background was subtracted to perform the
peak fitting with a symmetric Gauss-Lorentz sum function
(SpecSurf software).
2.6. Microbiological Evaluation. To determine the antibacte-
rial efficacy of the conjugates, Escherichia coli (ATCC 8739)
and Pseudomonas aeruginosa (ATCC 27853) were used as
Gram-negative models because of their epidemiologic and
clinical importance. Antimicrobial activity of the NPs with
or without conjugation was expressed in terms of minimum
inhibitory concentration (MIC). Evaluated NPs and conju-
gates were AuNP, AuNP-SDS, AuNP-UBI, AgNP, AgNP-SDS,
AgNP-UBI, and UBI (free peptide). NaCl 0.9% solution was
employed as a growth control. Due to the high difficulty
in determining the exact nanoparticle concentration, all
nanoparticle suspensions and conjugates were standardized
spectrophotometrically to 1 a.u. of absorbance and expressed
as mass silver or gold concentrations. Titration showed that
the standardized solutions contained 637 ± 74𝜇gmL−1 of Au
and 588 ± 19 𝜇gmL−1 of Ag. To obtain a range in nanoparticle
concentrations, 1, 2, 3, 4, and 5mL aliquots of standardized
NPswere placed in test tubes and completed to 6mLwith dis-
tilledwater, representing 106, 424, 955, 1698, and 2654𝜇gmL−1
of Au and 98, 392, 883, 1569, and 2452𝜇gmL−1 of Ag.
Microbiological evaluation was performed using a mod-
ified agar dilution method. Briefly, Muller-Hinton agar was
hydrated (77%), sterilized, and mixed with 1mL of nanopar-
ticle solution. The final volume was completed to 20mL
with sterilizedmedium.Themodified agar was slowly mixed,
poured into petri dishes for gelation, and posteriorly incu-
bated 24 h for microbiological control. Final concentrations
for modified Agar-NP media were 5, 20, 46, 81, 126, and
182 𝜇gmL−1 of Au and 5, 19, 42, 75, 117, and 168 𝜇gmL−1 for
Ag.
To determine the effect of the UBI peptide, different con-
centrations, ranging from 20𝜇M (0.33 𝜇gmL−1) to 0.06𝜇M
(0.001 𝜇gmL−1), were evaluated. Each experiment was car-
ried out in triplicate.
Inoculation was conducted in accordance with the CLSI
M07-A9 method [30], using a suspension equivalent to a 0.5
McFarland standard of E. coli and P. aeruginosa (1 to 2 ×
108 colony-forming units; CFU). Appropriate dilutions were
made from 10−1 to 10−6. Inoculation was performed with
2 𝜇L of the 10−1 dilution. Five inoculums were placed in the
previously prepared agar to obtain approximately 104 CFU
per spot. Aliquots of 10−6 were cultured in nanoparticle-free
agar as a growth control. Inoculated plates were inverted and
incubated at 35± 2∘C for 16–20 hours as an end point. Growth
of colonies was posteriorly evaluated.
2.7. Statistical Evaluation. Results were expressed as mean ±
standard deviation (SD). Statistical significance was verified
through Student’s t-test, considering a significance of 𝑝 <
0.05, unless otherwise indicated.
0.0
0.2
0.4
0.6
0.8
1.0
0.0
0.2
0.4
0.6
0.8
1.0
Ab
so
rb
an
ce
 (a
.u
.)
Ab
so
rb
an
ce
 (a
.u
.)
Wavelength (nm)
300 350 400 450 500 550 600
Wavelength (nm)
400 450 500 550 600 650 700
AgNP (426 nm)
AgNP-SDS (424 nm)
AgNP-UBI (428 nm)
AuNP (520 nm)
AuNP-SDS (523 nm)
AuNP-UBI (526 nm)
Figure 1: UV-Vis spectra of silver and gold nanoparticles stabilized
with SDS and functionalized with the UBI peptide.
3. Results and Discussion
3.1. Chemical Characterization
3.1.1. UV-Vis Spectroscopy. The citrate-stabilized AuNP and
AgNP spectra showed a surface plasmon resonance band
at 520 nm and 426 nm (Figure 1), respectively. It is well-
known that size, shape, and chemical environment modify
the dielectric constant at the nanoparticle surface [31]. A red-
shift was observed in the functionalized systems of AuNP-
SDS (3 nm), AuNP-UBI (6 nm), and AuNP (4 nm), which is
associated with an increase in the local refractive index at
the nanoparticle surface [32]. A blue-shift was observed for
AgNP-SDS (2 nm), which could be related to stabilization
by the coating surfactant, promoting the dispersion of small
aggregates.
The stability of functionalized NPs in water was moni-
tored by means of an SPR band for 6 months. There were not
significant modifications in intensity and width of the SPR
band.
3.1.2. Particle Size and Zeta Potential. TEM images of AgNP,
AgNP-UBI, AuNP, and AuNP-UBI showed monodispersed
solutions. Additionally, an increase in the volume mean
diameter was observed as an effect of peptide conjugation.
The interaction of stabilizer/peptide and peptide conjugation
was observed as a low electronic density around the gold
nanoparticle cores (Figure 2(b)).
The mean hydrodynamic diameters, determined by
DLS, showed no significant changes in stabilized SDS-
nanoparticles. Molero et al. determined that SDS-micelle
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Figure 2: Particle size analysis determined by DLS (a) and TEM (b).
formation at concentrations below 8mM has no significant
increase on micellar diameter [33]. Measured diameters were
12.3 ± 3.9 nm and 14.4 ± 4.3 nm for AgNP and AgNP-
UBI and 14.5 ± 5.7 and 16.5 ± 6.2 nm for AuNP and
AuNP-UBI, respectively (Figure 2(a)). Nanoparticles did not
show a significant change in dispersity; the slight increase
in diameters was attributed to adsorbed peptide and its
significant contribution to molecular weight.The Z-potential
of AgNP and AuNP was 96.5mV and 63.0mV, respectively,
and 113.9mV and 82mV for the AgNP-UBI and AuNP-
UBI, correspondingly, indicating that the peptide interaction
conferred a high colloidal stability to the nanosystems.
3.1.3. Infrared Spectroscopy. Themain vibrational frequencies
of the primary amine of Lys (3281 cm−1) and the amide I (at
1619 cm−1, C=O stretch) of the secondary amide observed
in the UBI spectrum (Figure 3(a)) were no longer seen as
defined bands in the AuNP-UBI and AgNP-UBI spectra
(Figures 3(b) and 3(c)). Instead, broad bands centered at
3294 cm−1 (Figure 3(b)) and 3257 cm−1 (Figure 3(c)) corre-
sponding to the secondary amide and bands at 1719 cm−1,
1589 cm−1 (Figure 3(b)), 1656 cm−1, and 1573 cm−1 (Fig-
ure 3(c)), related to primary amide I or II, are observed (in
the solid state, amides I and II may overlap). The interaction
of the NH2-lysine with the NP surface is also revealed in
the CH2-NH2 band position, which changed from 1179 cm
−1
(CH2/NH2 twisting vibration) to 1394 cm
−1 (Figure 3(b)) or
1389 cm−1 (Figure 3(c)) (CH2 wagging vibration) as a result
of a significant change of symmetry in the peptide due to the
NP-Lys-UBI interaction.This supports the argument that the
main bond in NP-UBI is through the amine NP-NH2-Lys-
UBI (Figure 3).
The AgNPs spectra are characterized by weak and broad
band centred at 3369 cm−1 from (COO-H)st vibrations, a
broad and intense band from (C-H)𝛿 vibrational modes from
citrate skeletal are localized at 1390 cm−1, and additional
vibrational modes (832–1100 cm−1) from citrate are observed.
AuNP shows strong bands between 3000–2700 cm−1
assigned to (>C-H2)st sy, 𝜐as (>C-H2)st as vibrational modes
and 1118–1258 cm−1 assigned to (COO-)st sy. In both cases,
predominant vibrational modes correspond to functional
groups of the citrate employed as a reducer agent and stabilizer
(see SupplementalMaterial Figure 1 in SupplementaryMaterial
available online at https://doi.org/10.1155/2017/5831959). Char-
acteristic spectra of dodecyl sulphate were obtained. SDS-
stabilizedNPs spectra were characterized by strong, multiple,
and well defined bands attributed principally to (-CH3)𝛿as
between 1470 and 1430 cm−1, (S=O)st as at 1225–980 cm
−1,
(S=O)st sy at 1200–1000 cm
−1, (C-O)st at 1200–1080 cm
−1,
(S-O)st at 870–690 cm
−1, and (C-H2)g between 770 and
720 cm−1 (see Supplemental Material Figure 2). The
spectra of UBI show a broad band between 3100 and 3500,
corresponding to (N-H)st, H-bonded (O-H)st, and (N-H)st
free vibrational modes. Strong bands corresponding to
amide I (C=O)st and amide II (N-C=O)st sy can be observed
between 1655–1630 cm−1 and 1560–1510 cm−1, respectively
(Figure 3(a)). Peptide-functionalized silver and gold NPs
(Figures 3(b) and 3(c)) show vibrational modes associated
with UBI. Vibrational modes of (C-H)st near 2925 cm
−1 and
(-CH2-O-)st, between 2880 and 2830 cm
−1, are attributable
to the hydrocarbon chain and ester bond from the SDS
employed as a stabilizing agent.
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Figure 3: IR-FT spectra of (a) UBI peptide and functionalized nanoparticles, (b) AgNP-UBI, and (c) AuNP-UBI.
3.1.4. Raman Spectroscopy. Significant spectral differences
were observed in functionalized silver and gold NPs with
respect to citrate-stabilized suspensions. Absence of Raman
signalling was observed for AuNP-citrate and AgNP-citrate
(Figures 4(a) and 4(c)), whereas peptide-functionalized NPs
(Figures 4(b) and 4(d)) showed broad bands in the region
of 1800 to 800 cm−1. In both systems, significant bands
attributable to amide I (C=O)st, amide II (N-H)st, and amide
III (C-N)st were observed near 1600, 1550, and 1231 cm
−1,
respectively. Additionally, bands with a significant contribu-
tion in intensity were observed at 1574 and 1542 cm−1, which
could be attributable to (C-N3)st from guanidine groups of
arginine, present in high concentration in the peptide. Skele-
tal chains of aliphatic (-CH2-) and methylene groups (-CH3)
could contribute to frequencies near 1410 and 1422 cm−1.
Additional vibrational bands of Tyr could be assigned at
685 and 820 cm−1. The latter is caused by characteristic
Fermi resonance between the in-plane breathing mode of the
phenol ring and an overtone of the out-of-plane deformation
mode. FT-IR and Raman spectroscopy were used to confirm
the surface modification of silver or gold nanoparticles with
the UBI peptide.
The vibrational modes from functionalized nanoparticles
are hardly sensitive to conformational changes and electro-
static interactions; shifts in vibrationalmodes from the amide
II region are correlated with the increase of strength of van
der Waal interactions with NP surfaces. The C-H stretching
band appears as superimposed bands under the prominent
O-H stretching in functionalized nanoparticles, with respect
to SDS or citrate-stabilized nanoparticles. This gives good
evidence that the molecules increase their intermolecular
hydrogen bonds and suggests that electrostatic interactions
play a determinant role in peptides bound to NP surfaces.
TEM and spectroscopy techniques demonstrated that
AgNPs andAuNPswere functionalizedwith theUBI peptide.
The IR spectrum of nanoparticles showed vibrational modes
from citrate, SDS, or peptides adsorbed onto the nanoparticle
surface.
3.1.5. XP Spectroscopy. The AuNP spectrum (Figure 5(a))
showed two main peaks corresponding to the binding ener-
gies (BE, eV) of electrons in Au 4f orbitals at 87.2 eV (Au 4f5/2)
and 83.3 eV (Au 4f7/2) and the deconvoluted spectrum for
Au 4f7/2 showed peaks at 83.9 and 83.2 eV, the first probably
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Figure 4: Raman spectra for (a) AgNP-citrate, (b) AgNP-UBI, (c) AuNP-citrate, and (d) AuNP-UBI.
due to weak bond with oxygen by electrostatic forces to
metallic gold core and phosphate groups of surfactant. For Ag
spectrum (Figure 5(b)) 3d3/2-5/2 core level binding energies
appear at 374.1 and 368.1 eV, respectively, in good agreement
with bulk silver metallic values, corresponding to the pres-
ence of fcc metallic silver structures found in nanoparticles.
Deconvoluted Ag 3d5/2 spectra can be fitted in terms of two
different chemically species with binding energies at 368.5
and 367.8 eV, assigned to metallic silver (Ag0) and silver ions
in Ag2O (Ag+), respectively, in agreement with previous
reports [34, 35].
3.2. Microbiological Assay. Table 1 shows the minimum NP
concentrations required to inhibit growth of E. coli and P.
aeruginosa. A statistically significant difference was observed
between noncapped gold and silver nanoparticles, whereas
AuNP and gold-functionalized nanoparticles seem to need
high NP concentration to produce a significant deleterious
effect on microbial growth. AgNPs showed an important
effect over both evaluated microorganisms. Significant activ-
ity was observed with functionalized NPs when compared
with citrate or SDS-stabilized NPs. The free peptide did not
show any inhibitory effect at the evaluated concentrations.
The mechanism of nanoparticle interaction with ionic
surfactants has not been completely elucidated yet. However,
[36] suggests a possiblemechanismof SDSdistribution on the
NP surface, in which the hydrophilic groups of the surfactant
molecules are adsorbed onto the nanoparticle surface and the
Journal of Nanomaterials 7
300
350
400
450
500
550
600
650
In
te
ns
ity
BE (eV)
92 90 88 86 84 82 80 78
4f5/2, 4f7/2
(a) AuNP-UBI
1550
1600
1650
1700
1750
1800
In
te
ns
ity
378 376 374 372 370 368 366 364
3d3/2, 3d5/2
BE (eV)
(b) AgNP-UBI
Figure 5: XPS spectra for (a) AuNP-UBI and (b) AgNP-UBI.
hydrophobic tails are directed outward to form the first layer.
Consequently, a counter-layer is oriented the opposite way,
resulting in interpenetration of the surfactant hydrophobic
tails between the two layers with hydrophilic groups headed
outward [13]. The addition of cationic surfactant is justified
by at least two reasons. The first is an increase of colloidal
stability of zero valent nanoparticles, enhanced by steric
repulsion from adsorbed surfactants and the balance in
electrostatic forces, following a possible mechanism in which
surfactant molecules form a compact micellar layer with
hydrophilic groups oriented to the nanoparticle surface. The
second justification is related to the increase of peptide
interaction with the nanoparticle surface through the use
of the surfactant bilayer’s capability to adsorb and stabilize
the peptide by electrostatic interactions between anionic,
cationic, and nonpolar domains of the peptide. Additionally,
it has been reported that ionic surfactants are adsorbed in
a less-compact mode at the nanoparticle surface compared
to nonionic surfactants [37]. Established mechanisms have
demonstrated that silver nanoparticles have a higher antimi-
crobial activity compared to free silver ions. Additionally, the
Ag+ ions delivered by nanoparticles located within the cell
increase the antibacterial activity.
Reported bactericidal effects from gold NPs are still
controversial. A great variability in MIC exists, attributable
mainly to microorganism type, specific conditions of partic-
ular procedures, as well as diffusion mechanisms in growth
media, support materials (applicable in disc procedures),
biofilm formation, and so forth. It is important to note
the differences in analytical procedures for microbiological
evaluation; in most cases, analysis was carried out by disk
Table 1: Minimum concentrations needed to inhibit the growth of
bacterial cells.
MIC (𝜇gmL−1)∗
E. coli P. aeruginosa
AuNP >182 >182
AuNP-SDS >182 >182
AuNP-UBI >182 >182
AgNP 130.6 ± 0.5 >168
AgNP-SDS 114.7 ± 1.7 150 ± 10
AgNP-UBI 89.3 ± 1.9 110 ± 3.5
∗MIC expressed in gold, silver, or peptide concentration required to inhibit
bacterial growth.
diffusion assay onMu¨ller-Hinton agar plates. However, in our
experience, there are significant disadvantages in such proce-
dure. We have observed that the interaction of nanoparticles
with adsorbent materials does not demonstrate the same
behaviour as with the desorption process. Interaction with
fibres could modify nanoparticle nature observed by signifi-
cant alteration in nanoparticle-support colour. In this sense, it
is difficult to establish a relationship between previous reports
based on exposure concentrations.
The NP microbicidal effect has been associated with
bacteria class. In E. coli, complete growth was impeded with
AgNP concentrations above 75𝜇gmL−1. However, evidence
demonstrates that the shape of AgNPs determines their
deleterious effects. The most effective antibacterial activity
has been observed with triangular nanoparticles [38, 39].
In this research, synthetized silver nanoparticles showed a
variable distribution in nanoparticle shape, with a predom-
inant spheroidal form. These and other factors associated
with the particular development of the methodology could
be responsible for the increase of the MIC in noncapped
AgNPs. For example, Rai et al. reported a weak bactericidal
activity (<10% of inhibition) on S. aureus exposed for 6 h
to 500 𝜇gmL−1 of AgNPs of 23- to 52 nm diameter [18].
The absence of inhibition was most likely attributable to
the presence of a peptidoglycan layer on the cell walls of S.
aureus, which does not allow for the penetration of AgNPs.
Umamaheswari et al. reported MCI80 on E. coli, S. typhi, P.
aeruginosa, and K. pneumoniae, which ranged from 20 to
40 𝜇gmL−1 with a damage mechanismmediated by ROS and
loss of membrane integrity [40].
The diversity in results showed that microbicidal effects
are limited to certain types of microorganisms and the inter-
action with the cellular microenvironment, such as cell wall,
glycocalyx, slime layer, or biofilm formation, since differences
in peptidoglycan composition, variations in the peptide stem,
and particular cross-linking determine nanoparticle diffu-
sion. Additionally, certain variations were observed between
members of the same species and the species themselves,
depending on growth conditions such as growth phase,media
composition, and presence of antibiotics [41].
In one particular case, a concentration of 182 𝜇gmL−1
of gold nanoparticles was insufficient to produce cellular
damage in Gram-negative microorganisms (Figure 6(a)),
8 Journal of Nanomaterials
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Figure 6: Effect on bacterial growth of Escherichia coli and Pseudomonas aeruginosa exposed to UBI peptide, silver and gold nanoparticles,
and conjugate AuNP-UBI or AgNP-UBI.
but a significant increase in inhibition was observed with
silver nanoparticles. Specifically, a decrease of 31.6% for
E. coli and 38% for P. aeruginosa was observed when the
peptide was conjugated to silver (Figure 6(b)). We propose
that the enhanced mechanisms of the antimicrobial agent
could be attributable to at least two effects. The first is
the local concentration increase of peptide surrounding the
nanoparticle and the intrinsic effect of the nanoparticle,
including the release of silver ions from the nanoparticle core.
As with silver nanoparticles, the gold cores increase the local
concentration of peptide. However, the damage mechanisms
differ significantly with respect to AgNP. The nature of the
damage produced by silver nanoparticles has been widely
studied, even though the specific mechanisms have not yet
been elucidated.
We demonstrated that the antimicrobial activity pro-
duced by silver nanoparticles was modified when antimicro-
bial peptides were bound to the nanoparticle surface. The
effect was determined using two microorganisms represen-
tative of the Gram-negative group, E. coli and P. aeruginosa.
However, in order to prove their therapeutic potential, the
AgNP-UBI conjugate needs to be tested on in vivo models.
Silver nanoparticles conjugated to antimicrobial peptides
increase the antibacterial activity against Gram-negative
bacteria providing a promising alternative therapy for topical
infections.
4. Conclusions
Currently, an intense investigation in nanotechnology and its
applications in infectious or contagious diseases has led to the
development of antimicrobial formulations from nanoparti-
cles that act as an effective bactericidal agent. In this study,
it was demonstrated that an increase in the antibacterial
activity against Gram-negative bacteria appears when silver
nanoparticles are capped with the UBI antimicrobial peptide,
probably due to the multimeric or polyvalent arrangement
of ligands distributed on the nanoparticle surface. Additional
studies are required to understand the structure of multi-
valent nanoparticles and stabilization mechanisms not yet
elucidated.
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